BioSpace News Archive

Benitec Biopharma Inc. announced that it has entered into an underwriting agreement with H.C. Wainwright & Co. under which the underwriter has agreed to purchase on a firm commitment basis 1,764,705 shares of common stock of the Company at a price to the public of $4.25 per share, less underwriting discounts and commissions.

AnPac Bio-Medical Science Co., Ltd., a biotechnology company with operations in China and the United States, announced that it plans to report its fiscal year 2020 unaudited financial results ended December 31, 2020, before the open of U.S. markets on Friday, April 30, 2021.

STERIS plc announced that it will host a conference call to discuss its fiscal 2021 fourth quarter and full year financial results at 11:00 a.m. ET on Wednesday, May 19, 2021.

Amedisys, Inc., a leading provider of home health, hospice and personal care, in collaboration with Sound Physicians, a leading physician practice partner to health systems and plans, physician groups and post-acute providers, will launch the Home Health Advanced Program in the southeastern United States.

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today announced that clinical, preclinical and manufacturing data from its investigational gene therapy programs will be presented at the American Society of Gene & Cell Therapy (ASGCT) 24th Annual Meeting

Vitro Biopharma recorded quarter ended January 31st, 2021 revenues of $ 127,492 vs $225,921 a decrease of 44% over the prior comparative quarter directly attributed to the COVID-19 pandemic.

Marker Therapeutics, Inc. (Nasdaq:MRKR), today announced that it will present data detailing a new robotics technology to aid in multi-tumor-associated antigen (mTAA)-specific T cell therapy manufacturing at the upcoming American Society of Gene & Cell Therapy (ASGCT) Annual Meeting,

Eurofins Viracor, one of the largest and most recognized infectious diseases testing laboratories in the United States, and Transplant Genomics, the trusted global partner in precision biomarkers for the transplant community innovating to improve patient outcomes, announce that the New York State Department of Health Clinical Laboratory Evaluation Program

Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the Centers for Medicare and Medicaid Services (CMS) published the Fiscal Year 2022 Hospital Inpatient Prospective Payment System (IPPS) Proposed Rule,

Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “the Company”), today announced that, due to demand, the underwriter has agreed to increase the size of the previously announced offering and purchase on a firm commitment basis 3,036,366 shares of common stock